Literature DB >> 10370648

Palliative treatment of esophageal cancer: self-expanding metal stents versus Postlethwait technique.

R Cantero1, A J Torres, F Hernando, J Gallego, A Lezana, A Suarez, J L Balibrea.   

Abstract

BACKGROUND/AIMS: The development of new techniques for palliation of esophageal carcinoma with lower morbidity and mortality than surgical procedures.
METHODOLOGY: Between 1981 and 1994, 258 patients with esophageal and cardiac cancer were treated in our Department. We selected two groups: Group A, 25 patients underwent a by-pass with an isoperistaltic gastric tubular (Postlethwait technique) and, group B, in 30 patients we placed 35 autoexpandable esophageal stents. We subsequently performed a retrospective study.
RESULTS: In group A, dysphagia was not relieved in 6 patients (24%) and we found no complications in 18 patients (72%). The hospitalization period ranged from 18-50 days. Hospital mortality rate was 24% (6 patients). Mean survival was 5.4 months (range: 3-9 months). All patients in group B, except for 2, were relieved of dysphagia. Two patients (6.6%) died in the immediate post-intubation period though none of the deaths were related to technical complications. Hospitalization period ranged from 5-12 days. Mean survival was 6 months (range: 12 days to 9 months).
CONCLUSIONS: Currently, surgical by-pass procedures are restricted to the patient with an incurable disease not identified until operation time.

Entities:  

Mesh:

Year:  1999        PMID: 10370648

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Bypass Operation for Unresectable Esophageal Cancer: Postoperative Complications After Thoracotomy Versus No Thoracotomy.

Authors:  Masahiro Kimura
Journal:  Indian J Surg       Date:  2016-04-05       Impact factor: 0.656

2.  Advanced esophageal cancer with tracheobronchial fistula successfully treated by esophageal bypass surgery.

Authors:  Masahiro Kimura; Hideyuki Ishiguro; Tatsuya Tanaka; Hiromitsu Takeyama
Journal:  Int J Surg Case Rep       Date:  2015-03-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.